Chenshi Lin

753 total citations · 1 hit paper
18 papers, 582 citations indexed

About

Chenshi Lin is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chenshi Lin has authored 18 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chenshi Lin's work include Nanoparticle-Based Drug Delivery (4 papers), Pharmacology and Obesity Treatment (2 papers) and MicroRNA in disease regulation (2 papers). Chenshi Lin is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Pharmacology and Obesity Treatment (2 papers) and MicroRNA in disease regulation (2 papers). Chenshi Lin collaborates with scholars based in China, United States and United Kingdom. Chenshi Lin's co-authors include Wei He, Chao Teng, Chao Qin, Xiaopeng Han, Lifang Yin, Lei Yang, Qingqing Xiao, Makhloufi Zoulikha, Xiaotong Li and Marwa A. Sallam and has published in prestigious journals such as ACS Nano, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Chenshi Lin

14 papers receiving 577 citations

Hit Papers

The effects of protein corona on in vivo fate of nanocarr... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenshi Lin China 8 241 236 219 75 65 18 582
Weixi Jiang China 15 101 0.4× 137 0.6× 261 1.2× 104 1.4× 71 1.1× 22 574
Tsang-Pai Liu Taiwan 15 138 0.6× 348 1.5× 147 0.7× 132 1.8× 67 1.0× 23 747
Makhloufi Zoulikha China 9 182 0.8× 308 1.3× 205 0.9× 86 1.1× 129 2.0× 10 719
Kai Guo China 15 185 0.8× 274 1.2× 234 1.1× 73 1.0× 117 1.8× 38 666
Jian-Bin Qiao China 14 267 1.1× 299 1.3× 268 1.2× 122 1.6× 62 1.0× 20 811
Diêgo S. Ferreira Brazil 14 158 0.7× 176 0.7× 134 0.6× 65 0.9× 55 0.8× 23 526
Xinzhu Shan China 9 172 0.7× 257 1.1× 322 1.5× 102 1.4× 176 2.7× 9 585
Zheng Pan China 10 106 0.4× 227 1.0× 229 1.0× 150 2.0× 75 1.2× 28 764
Rufang Liao China 11 145 0.6× 179 0.8× 245 1.1× 120 1.6× 66 1.0× 13 583

Countries citing papers authored by Chenshi Lin

Since Specialization
Citations

This map shows the geographic impact of Chenshi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenshi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenshi Lin more than expected).

Fields of papers citing papers by Chenshi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenshi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenshi Lin. The network helps show where Chenshi Lin may publish in the future.

Co-authorship network of co-authors of Chenshi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chenshi Lin. A scholar is included among the top collaborators of Chenshi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenshi Lin. Chenshi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Mei, Yiyue Zhang, Jinlong Jiao, et al.. (2025). Bletilla striata polysaccharide protects against UVA-induced skin damage by activating Nrf2/HO-1 signaling and inhibiting ferroptosis. Carbohydrate Polymers. 370. 124360–124360.
2.
Yang, Shuiqing, Wenbin Li, Chenshi Lin, et al.. (2025). Amylase-producing lung adenocarcinoma with an anaplastic lymphoma kinase fusion mutation: a case report. Laboratory Medicine. 56(6). 782–785.
3.
Wang, Mei, et al.. (2025). Exploring machine learning strategies for single-cell transcriptomic analysis in wound healing. Burns & Trauma. 13. tkaf032–tkaf032. 1 indexed citations
5.
Lin, Chenshi & Hong Ma. (2024). The Therapeutic Potential of Metformin for Metabolic Associated Fatty Liver Disease: Bioinformatics Analysis. Archives of Clinical and Medical Case Reports. 8(1).
7.
Lin, Chenshi, et al.. (2023). A Case of Pseudohypoparathyroidism Misdiagnosed as Idiopathic Epilepsy for 5 Years: Clinical Analysis and Follow-up Outcomes. Journal of International Medical Research. 51(11). 3639276130–3639276130. 1 indexed citations
8.
Liu, Jie, Chenshi Lin, Yingjie Wang, et al.. (2023). Co-delivery of indomethacin and uricase as a new strategy for inflammatory diseases associated with high uric acid. Drug Delivery and Translational Research. 14(7). 1820–1838. 5 indexed citations
10.
Xiao, Qingqing, Makhloufi Zoulikha, Min Qiu, et al.. (2022). The effects of protein corona on in vivo fate of nanocarriers. Advanced Drug Delivery Reviews. 186. 114356–114356. 165 indexed citations breakdown →
11.
Li, Bingbing, Chao Teng, Xiaohong Jiang, et al.. (2022). Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries. Acta Pharmaceutica Sinica B. 13(6). 2369–2382. 25 indexed citations
12.
Zhang, Sen, et al.. (2022). CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma. Medicine. 101(30). e29796–e29796. 2 indexed citations
13.
Teng, Chao, Bingbing Li, Chenshi Lin, et al.. (2021). Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension. Journal of Controlled Release. 341. 591–604. 39 indexed citations
14.
Hasib, Annie, Chenshi Lin, Rory J. McCrimmon, et al.. (2021). Adipocyte integrin-linked kinase plays a key role in the development of diet-induced adipose insulin resistance in male mice. Molecular Metabolism. 49. 101197–101197. 16 indexed citations
15.
Teng, Chao, Chenshi Lin, Xuyang Xing, et al.. (2020). Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease. Acta Pharmaceutica Sinica B. 10(8). 1521–1533. 47 indexed citations
16.
Teng, Chao, Zhongyue Yuan, Chenshi Lin, et al.. (2019). Desirable PEGylation for improving tumor selectivity of hyaluronic acid-based nanoparticles via low hepatic captured, long circulation times and CD44 receptor-mediated tumor targeting. Nanomedicine Nanotechnology Biology and Medicine. 24. 102105–102105. 21 indexed citations
17.
Lv, Yaqi, Chaoran Xu, Xiangmei Zhao, et al.. (2018). Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells. ACS Nano. 12(2). 1519–1536. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026